Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO WHO and other public health institutions have complex relations with commercial entities that supply health care products and...
May 10, 2011 Health Action International (HAI) Europe, Medicines in Europe Forum (MiEF) and the International Society of Drug Bulletins (ISDB) congratulate the European Parliament on calling for the European Court of Auditors to evaluate the...
By MARC-ANDRÉ GAGNON, Troy Media April 19, 2011 By implementing universal Pharmacare and eliminating various policies, we could save $10.7B per year. This money can be invested by improving health care and publicly funding medical research Read more: http://www.montrealgazette.com/health/system+broken/4639165/story.html#ixzz1KfSGlVDy...
Kesselheim AS, Mello MM, Studdert DM, 2011 Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints. PLoS Med 8(4):e1000431. doi:10.1371/journal.pmed.1000431 Background: Despite regulatory restrictions, off-label marketing of pharmaceutical products has been...